3,344
Participants
Start Date
July 15, 2016
Primary Completion Date
February 28, 2017
Study Completion Date
February 28, 2017
Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine
0.5 mL, Intramuscular
Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine
0.5 mL, Intramuscular
Upper Saint Clair
McMurray
Hermitage
Erie
Burke
Charlottesville
Midlothian
Richmond
Raleigh
Raleigh
Salisbury
Charlotte
Charleston
Charleston
Mt. Pleasant
Charlottesville
Savannah
DeLand
Orlando
Hialeah
Hialeah
Miami
South Miami
West Palm Beach
St. Petersburg
Sarasota
Birmingham
Dothan
Mobile
Nashville
Tullahoma
Jackson
Bardstown
Cleveland
Cincinnati
Cincinnati
Dayton
Dayton
Council Bluffs
Fargo
Lincoln
Bridgeton
St Louis
Kansas City
Lenexa
Newton
Wichita
Wichita
Park City
Omaha
Omaha
Lincoln
Metairie
Jonesboro
Harrisburg
Waxahachie
Fort Worth
Fort Worth
San Antonio
Corpus Christi
Littleton
Meridian
West Jordan
Draper
Layton
Orem
West Jordan
South Jordan
Salt Lake City
Salt Lake City
Murray
Phoenix
Mesa
Glendale
Los Angeles
Downey
Paramount
Upland
West Covina
San Diego
San Diego
Anaheim
Santa Rosa
Sacramento
Redding
San Diego
Corvallis
Grants Pass
Warwick
Sanofi Pasteur, a Sanofi Company
INDUSTRY